Chicago AI Errors: Who Pays in 2026?

The rise of automated medical decision-making systems in healthcare presents a complex legal field, particularly concerning error liability. There is significant misinformation circulating about who bears responsibility when these advanced systems, designed to assist clinicians, lead to adverse patient outcomes in settings like Chicago hospitals. Understanding the true allocation of liability is critical for patients, providers, and developers alike.

Myth 1: The AI is always to blame for its own mistakes.

Many believe that if an automated medical system, often referred to as AI, makes a flawed recommendation that causes harm, the system itself or its developer automatically shoulders all liability. This is a deep misunderstanding of how legal frameworks apply to technology in healthcare. The reality is far more nuanced. While the software’s role is central, liability doesn’t simply transfer wholesale to the algorithm. Instead, we typically see a multifaceted analysis involving product liability and medical malpractice principles.

Consider a scenario in a Chicago hospital, perhaps at Northwestern Memorial, where an automated diagnostic tool suggests an incorrect treatment path, and a physician follows it without sufficient critical review. The physician’s responsibility to exercise independent medical judgment remains paramount. The Illinois Medical Practice Act of 1987, specifically 225 ILCS 60, outlines the standards of care expected from licensed medical professionals. A physician cannot simply defer all decision-making to a machine without scrutiny. If a reasonable and prudent physician would have identified the error or performed additional verification, then the physician could face a medical malpractice claim.

Hurt by a medical mistake?

Know what your case is worth with AI Medical Payout Calculator for FREE!

Start my free evaluation

However, this doesn’t absolve the developer. If the automated system had a design defect, a flaw in its underlying algorithms, or insufficient testing, then the developer could be liable under product liability law. This would fall under strict liability in Illinois, meaning the plaintiff wouldn’t need to prove negligence on the part of the manufacturer, only that the product was defective and unreasonably dangerous. The challenge lies in proving the defect and the direct causation to the patient’s injury. It’s not an either or situation. Both parties could potentially share responsibility depending on the specifics of the case.

Myth 2: Developers are immune because their software is “just a tool.”

There’s a common misconception that software developers can escape liability by arguing their automated medical systems are merely tools, and the human user is in the end responsible. This argument often fails, particularly when the software functions as a medical device. The U.S. Food and Drug Administration (FDA) has clear guidelines on Software as a Medical Device (SaMD), classifying software that performs a medical purpose without being part of a hardware medical device. According to the FDA’s “Clinical Decision Support Software” guidance published in September 2022, if the software provides patient-specific recommendations that clinicians rely on for diagnosis or treatment, it’s subject to stringent regulatory oversight.

A developer of an automated medical system used in Chicago’s Rush University Medical Center, for instance, must ensure their product meets FDA requirements for safety and effectiveness. Failure to do so can directly impact liability. If a system’s algorithm, despite being “just software,” consistently misinterprets patient data, leading to a delayed diagnosis of a critical condition like sepsis, the developer faces significant exposure. The legal precedent here often mirrors that of defective physical medical devices. A report from the U.S. Government Accountability Office (GAO) in 2023 highlighted concerns about the safety and efficacy of AI in healthcare, suggesting a need for strong pre-market and post-market oversight.

Plus, even if the software isn’t strictly classified as a medical device, inadequate warnings or instructions can still lead to liability. If the developer fails to clearly communicate the system’s limitations, potential biases, or the specific scenarios where it might perform poorly, and this lack of warning contributes to an error, they could be held responsible. This isn’t about the software being a “tool”. It’s about the developer’s duty to provide a safe and adequately described product for its intended use.

Myth 3: Proving causation in automated medical errors is impossible.

Many assume that the complexity of automated medical systems makes it nearly impossible to trace an error back to its source and prove it caused patient harm. This perspective overstates the difficulty of forensic analysis in modern litigation. While challenging, establishing causation is a routine aspect of medical malpractice and product liability cases, even with advanced technology.

In a case involving an automated medical Chicago system, attorneys would typically engage experts in fields like biomedical engineering, computer science, and clinical informatics. These experts can analyze the system’s logs, algorithms, and training data. For example, if an automated system at Advocate Illinois Masonic Medical Center consistently misidentified malignant lesions on radiology scans, experts could examine the system’s image recognition algorithms and the dataset it was trained on. They might find that the training data was insufficient, biased, or contained errors that led to the system’s faulty performance.

The key is linking the system’s specific flaw to the patient’s injury. This often involves a “but for” test: “But for the error in the automated system, would the injury have occurred?” If a patient suffered a preventable stroke because an automated system failed to flag a critical risk factor, and a human physician, relying on that system, missed it, the causal chain can be established. This requires careful data analysis and expert testimony, but it’s far from impossible. The National Institutes of Health (NIH) in 2024 announced initiatives to improve trustworthy AI in biomedical research, acknowledging the need for transparent and explainable AI to ensure accountability.

Myth 4: Disclaimers shield providers and developers from all liability.

It’s common to see disclaimers on software, stating that the user is in the end responsible for decisions. While disclaimers play a role, they do not offer an impenetrable shield against liability, especially in the context of healthcare. In Illinois, as in most jurisdictions, disclaimers are subject to scrutiny, particularly when they attempt to limit liability for negligence or defective products that cause personal injury.

For a healthcare provider using an automated system, a disclaimer from the software developer stating “this is for informational purposes only” or “clinician judgment always prevails” does not absolve the provider of their professional duties. If a physician at a facility like the University of Chicago Medical Center relies solely on a system’s recommendation without applying their own expertise, they could still be found negligent. The standard of care for physicians in Illinois is defined by what a reasonably prudent physician would do under similar circumstances, not by what a software disclaimer permits.

Similarly, developers cannot simply disclaimer away their responsibility for inherently defective products. If an automated system has a known, unaddressed bug that leads to incorrect dosage calculations, a disclaimer won’t protect the developer from product liability claims. Courts often look at whether the disclaimer was conspicuous, understood by the user, and if it attempts to waive fundamental rights or duties. For instance, Illinois’ Uniform Commercial Code (810 ILCS 5/2-316) addresses limitations on warranties, highlighting that certain implied warranties, especially for fitness for a particular purpose, can be difficult to disclaim effectively in consumer or professional contexts where reliance is expected.

Myth 5: Patients have no recourse if their insurance denies coverage based on an automated decision.

A worrying myth is that if an automated system, perhaps used by an insurance company, denies coverage for a necessary medical procedure, the patient has no effective recourse. This is incorrect. While automated systems are increasingly used in insurance claims processing, patients retain significant rights and avenues for appeal.

In Illinois, patients whose coverage is denied based on an automated decision can typically pursue an internal appeal with their insurance company. If that fails, they can often escalate to an external review process, often overseen by the Illinois Department of Insurance. These processes allow for a human review of the automated decision, often involving independent medical professionals. The insurance company’s use of an automated system does not override their contractual obligations to policyholders or regulatory requirements for fair claims processing. The Centers for Medicare & Medicaid Services (CMS), for example, has strict rules regarding adverse coverage determinations, requiring clear explanations and appeal rights, regardless of whether the initial decision was automated.

Plus, if an automated system used by an insurer is found to be systematically biased or flawed, leading to widespread improper denials, it could open the door for class-action lawsuits or regulatory action. The use of AI in healthcare, including insurance, is under increasing scrutiny to ensure fairness and prevent discrimination. Patients should never assume an automated denial is the final word. Persistence through the appeals process is important.

The rapidly evolving field of automated medical decision-making in Chicago and beyond demands a clear understanding of error liability. While these systems promise efficiency, they introduce complex questions of responsibility that require careful legal analysis, expert testimony, and a commitment to patient safety above all else.